Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/15/2026

1. IBM
2. SPY
3. LCID
4. JPM
5. ERAS
6. BAC
7. TREX
8. AAPL
9. WFC
10. ORCL

Go back to Amarin (AMRN) Vascepa Growth Continues; Sees Limited Negative Read-Through from Merck's HPS2-THRIVE
Amarin Corp Plc (NASDAQ: AMRN) Delayed: 14.37 -0.33 (2.24%)
Previous Close $14.70    52 Week High $3.65 
Open $14.66    52 Week Low $1.24 
Day High $14.81    P/E N/A 
Day Low $14.30    EPS $0.00 
Volume 51,972